Baselake Partners, LP 13D and 13G filings for Neuphoria Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-06 4:29 pm Unchanged | 2025-12-31 | 13G | NEUPHORIA THERAPEUTICS INC NEUP | Baselake Partners, LP | 222,222 4.100% | 0 (Unchanged) | Filing |
| 2025-10-31 4:31 pm Purchase | 2025-10-27 | 13G | NEUPHORIA THERAPEUTICS INC NEUP | Baselake Partners, LP | 222,222 9.400% | 222,222 (New Position) | Filing |